Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

KP-1461 begins phase Ib study for HIV

Oct. 18, 2005

Updated HIV/AIDS treatment guidelines support Fuzeon + PI use

Oct. 17, 2005

VRC begins phase II testing of HIV vaccine developed with GenVec

Oct. 17, 2005

VIRxSYS completes financing

Oct. 14, 2005

Novel therapeutic agents for HIV infection disclosed

Oct. 11, 2005

GenVec and Vaccine Research Center HIV research program boosted by investment

Oct. 10, 2005

FDA request further phase II study for Reverset prior to phase III

Sep. 30, 2005

New anti-HIV agents described in recent patents

Sep. 27, 2005

Tripep advances alpha-HGA to phase I/II trial for HIV

Sep. 26, 2005

Novel anti-HIV agents reported by Kumamoto

Sep. 20, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.